55 completed. 55 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 55 | Completed 55 |
Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ropivacaine Plus Magnesium Sulphate Infiltration Placebo Comparator: N/S 0.9%, Ropivacaine 10%, Ropivacaine 10% plus magnesium sulphate 10mg/kg - Thyroid Diseases, Parathyroid Diseases | Phase 4 | Completed | Aristotle University Of Thessaloniki | 68 | 2022-01-19 | 2024-07-17 |
| Lidocaine And Neuromonitoring in Thyroid Surgery Intravenous lidocaine, Intravenous placebo, Intra-cuff lidocaine - Thyroid Neoplasm, Parathyroid Neoplasms | Phase 4 | Completed | Saint Petersburg State University, Russia | 110 | 2021-01-25 | 2024-03-21 |
| Efficacy of Calcium Citrate Versus Calcium Carbonate for the Management of Chronic Hypoparathyroidism Calcium Carbonate, Calcium Citrate - Chronic Hypoparathyroidism | Phase 4 | Completed | Campus Bio-Medico University | 26 | 2019-10-15 | 2020-04-03 |
| Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment Indocyanine Green - Thyroid Cancer, Thyroid Goiter | Phase 4 | Completed | University Health Network, Toronto | 10 | 2019-08-06 | 2020-03-27 |
| Minimizing Narcotic Analgesics After Endocrine Surgery Acetaminophen 500Mg Cap, Tylenol #3 Oral Tablet, Tramadol - Thyroid Cancer, Thyroid Nodule | Phase 4 | Completed | Minerva A Romero Arenas | 126 | 2018-03-09 | 2021-05-11 |
| Different Effects of Non-calcium Phosphate Binders on Serum Calcium Sevelamer Hydrochloride, Lanthanum Carbonate - Chronic Kidney Disease | Phase 4 | Completed | Medical University of Lodz | 34 | 2018-03-01 | 2021-07-27 |
| A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE) rhPTH (1-84), Placebo - Hypoparathyroidism | Phase 4 | Completed | Shire | 93 | 2018-01-24 | 2023-06-09 |
| Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients cardiac MRI, echocardiography with strain, Laboratory tests - Secondary Hyperparathyroidism, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 4 | Completed | Rainer Oberbauer | 62 | 2017-10-01 | 2020-06-09 |
| Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT Cinacalcet HCl - Hyperparathyroidism; Secondary, Renal | Phase 4 | Completed | Kyowa Kirin China Pharmaceutical Co., Ltd. | 750 | 2017-04-19 | 2024-04-29 |
| A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism rhPTH(1-84) - Chronic Hypoparathyroidism, Hypoparathyroidism | Phase 4 | Completed | Shire | 39 | 2016-10-27 | 2021-07-28 |
| Cholecalciferol Supplementation Effect on Parathyroid Hormone in Hemodialysis Patients cholecalciferol, placebo - Vitamin D Deficiency, Hemodialysis Patient | Phase 4 | Completed | Cooperativa Asistencia Sindicato Médico Uruguay | 120 | 2015-10-15 | 2018-08-27 |
| Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. Paricalcitol, Calcifediol - Secondary Hyperparathyroidism Due to Renal Causes | Phase 4 | Completed | Fundación Senefro | 148 | 2014-01-01 | 2018-11-19 |
| The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid calcium sensing receptor agonist - Hyperparathyroidism, Secondary | Phase 4 | Completed | Chulalongkorn University | 60 | 2013-11-01 | 2017-03-28 |
| Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation Zoledronic acid - Renal Osteodystrophy | Phase 4 | Completed | University of Sao Paulo General Hospital | 34 | 2012-07-01 | 2014-05-19 |
| Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder Vitamin D2, 1,25(OH)2 Vit D3 - Vitamin D Deficiency | Phase 4 | Completed | Dongliang Zhang, MD | 204 | 2012-07-01 | 2016-02-15 |
| A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients Paricalcitol, Darbepoetin alfa - Moderate to Severe Secondary Hyperparathyroidism, Stage 5 Chronic Kidney Diseases | Phase 4 | Completed | AbbVie (prior sponsor, Abbott) | 65 | 2012-05-10 | 2021-07-30 |
| Vitamin D Repletion in Primary Hyperparathyroidism 10,000 IU Vitamin D3, Placebo, Vitamin D - Primary Hyperparathyroidism, Vitamin D Deficiency | Phase 4 | Completed | Columbia University | 9 | 2011-10-01 | 2019-04-16 |
| Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis Traditional Vitamin D Therapy, Cinacalcet - Hyperparathyroidism, Secondary | Phase 4 | Completed | Amgen | 312 | 2010-10-01 | 2018-10-17 |
| Paricalcitol Effect on Anemia in CKD Paricalcitol, Calcitriol - Anemia, Chronic Kidney Disease | Phase 4 | Completed | Federico II University | 60 | 2010-10-01 | 2014-07-30 |
| Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level cinacalcet, control - Secondary Hyperparathyroidism | Phase 4 | Completed | Seoul National University Hospital | 66 | 2010-09-01 | 2012-06-08 |
Showing 20 of 55. Sign in to see all of them.
Hyperparathyroidism, Secondary (34) · Renal Insufficiency, Chronic (17) · Hyperparathyroidism (10) · Kidney Failure, Chronic (7) · Vitamin D Deficiency (7) · Hypercalcemia (6) · Chronic Kidney Disease-Mineral and Bone Disorder (5) · Hyperparathyroidism, Primary (5) · Hypoparathyroidism (5) · Bone Diseases, Metabolic (4) · Osteoporosis (3) · Parathyroid Neoplasms (3) · Renal Insufficiency (3) · Thyroid Neoplasms (3) · Anemia (2)
Endocrine System Diseases (55) · Hyperparathyroidism (37) · Pathological Conditions, Signs and Symptoms (32) · Pathologic Processes (28) · Female Urogenital Diseases (27) · Female Urogenital Diseases and Pregnancy Complications (27) · Male Urogenital Diseases (27) · Urogenital Diseases (27) · Urologic Diseases (27) · Chronic Disease (26) · Disease Attributes (26) · Kidney Diseases (25) · Nutritional and Metabolic Diseases (22) · Renal Insufficiency (20)
Cinacalcet (17) · paricalcitol (16) · 1 alpha-hydroxyergocalciferol (9) · Calcitriol (6) · Vitamin D (5) · Ergocalciferols (4) · Cholecalciferol (3) · Sevelamer (2) · Acetaminophen (1) · Alendronate (1) · Atorvastatin (1) · Calcifediol (1) · Calcium Carbonate (1) · Calcium Citrate (1) · Capsules (1)
Amgen (8) · Abbott (6) · Genzyme, a Sanofi Company (4) · Shire (2) · AbbVie (prior sponsor, Abbott) (1) · Aristotle University Of Thessaloniki (1) · Campus Bio-Medico University (1) · Chinese University of Hong Kong (1) · Chulalongkorn University (1) · Clalit Health Services (1) · Columbia University (1) · Cooperativa Asistencia Sindicato Médico Uruguay (1) · Dongliang Zhang, MD (1) · Duke University (1) · Federico II University (1)
United States (20) · Italy (5) · Spain (4) · Austria (2) · Canada (2) · China (2) · Denmark (2) · France (2) · Germany (2) · Greece (2) · Hong Kong (2) · Netherlands (2) · Portugal (2) · Russia (2) · Sweden (2)
Aihua Zhang (1) · Aili Jiang (1) · Anat Tsur, MD (1) · Angela YM Wang, MD, PhD (1) · Anne F Cailleux, MD (1) · Bruno Niederle, Prof., MD (1) · Chaosheng Chen (1) · Csaba P. Kovesdy, M.D. (1) · Daniel W Coyne, MD (1) · David M Spiegel, MD (1) · Dongliang Zhang, Doctor (1) · Efstathios Mitsopoulos, MD (1)
PMID 17666472, PMID 18178780, PMID 18423809, PMID 19018785, PMID 19365139, PMID 19470620, PMID 20943783, PMID 22387567, PMID 22863242, PMID 23705925, PMID 24214232, PMID 24500308, PMID 24589316, PMID 24970869, PMID 25645432, PMID 25781618, PMID 25873267, PMID 31014177, PMID 31310310, PMID 31651370, PMID 32738041, PMID 33825489, PMID 34754193, PMID 35559350, PMID 35872799, PMID 35974422, PMID 36018496, PMID 36869794, PMID 37729887, PMID 37932788, PMID 38040277, PMID 40576086, PMID 40711996, PMID 41847596
2008 (2), 2009 (1), 2017 (1), R01DK084986 (1)